BNP Signaling Is Crucial For Embryonic Stem Cell Proliferation by Abdelalim, Essam Mohamed & Tooyama, Ikuo
BNP Signaling Is Crucial For Embryonic Stem Cell
Proliferation
Essam Mohamed Abdelalim
1,2*, Ikuo Tooyama
1
1Molecular Neuroscience Research Center, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Japan, 2Department of Cytology and Histology, Faculty of
Veterinary Medicine, Suez Canal University, Ismailia, Egypt
Abstract
Background: Embryonic stem (ES) cells have unlimited proliferation potential, and can differentiate into several cell types,
which represent ideal sources for cell-based therapy. This high-level proliferative ability is attributed to an unusual type of
cell cycle. The Signaling pathways that regulate the proliferation of ES cells are of great interest.
Methodology/Principal Findings: In this study, we show that murine ES cells specifically express brain natriuretic peptide
(BNP), and its signaling is essential for ES cell proliferation. We found that BNP and its receptor (NPR-A, natriuretic peptide
receptor-A) were highly expressed in self-renewing murine ES cells, whereas the levels were markedly reduced after ES cell
differentiation by the withdrawal of LIF. Targeting of BNP with short interfering RNA (siRNA) resulted in the inhibition of ES
cell proliferation, as indicated by a marked reduction in the cell number and colony size, a significant reduction in DNA
synthesis, and decreased numbers of cells in S phase. BNP knockdown in ES cells led to the up-regulation of gamma-
aminobutyric acid receptor A (GABAAR) genes, and activation of phosphorylated histone (c-H2AX), which negatively affects
ES cell proliferation. In addition, knockdown of BNP increased the rate of apoptosis and reduced the expression of the
transcription factor Ets-1.
Conclusions/Significance: Appropriate BNP expression is essential for the maintenance of ES cell propagation. These
findings establish BNP as a novel endogenous regulator of ES cell proliferation.
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Introduction
Embryonic stem (ES) cells have the remarkable capacity to
divide indefinitely while retaining their wide range differentiation
potential, and they represent a promising source for cell
transplantation therapies [1]. They exhibit a very unusual cell
cycle structure, characterized by a short G1 phase and a high
proportion of cells in the S phase [2,3], which is associated with a
unique mechanism of cell cycle regulation.
Brain natriuretic peptide (BNP), a member of natriuretic peptide
family, is produced predominately in the heart [4,5], and recently, we
have shown that BNP is expressed in ES cell-derived cardiomyocytes
[6].The physiological effects of natriuretic peptides are initiated by
binding to two particulate guanylate cyclase receptors; natriuretic
peptide receptor type A (NPR-A), which is sensitive to ANP (atrial
natriuretic peptide) and BNP [7], natriuretic peptide receptor type B
(NPR-B), which is specific for CNP (c-type natriuretic peptide) [8] to
produce intracellular cyclic guanosine monophosphate (cGMP) in
response to hormone binding [7]. Natriuretic peptides regulate blood
pressure and fluid homeostasis [9]. In addition, the abilities of
natriureticpeptidestomodulatecell growthandcellproliferation have
received attention [10]. Cell-based studies have shown that ANP and
BNP exhibit important autocrine and paracrine functions such as
modulating myocyte growth, apoptosis and proliferation in smooth
muscle cells [11]. BNP-transgenic mice exhibit overgrowth of the
growth plate cartilage through a cGMP-dependent mechanism [12].
Furthermore, signaling through NPR-A has been found to play a
pivotal role in tumor growth [13]. Although, little is known about the
role of natriuretic peptides in pre-implantation embryo development,
ithasbeenreportedthatNPR-B-deficientmicewere steriledue tolack
of development of the reproductive system, and the majority (75%) of
the NPR-B-deficient mice died before 100 days of age [14]. In
addition, it has been found that exogenous BNP can enhance clonal
propagation in murine ES cells [15], suggesting the presence of
functional natriuretic peptide receptors in ES cells.
To date, there is no data available concerning the expression of
BNP in ES cells. Therefore, in the present study we have
characterized the expression of BNP in undifferentiated ES cells,
and examined its role in regulating ES cell proliferation. We found
that BNP and its receptor NPR-A are specifically expressed in self-
renewing ES cells, and the BNP signaling plays an important role
in maintaining the proliferation of ES cells by inhibiting GABAAR
and Ets-1 genes.
Results
Expression of BNP and its receptors in pluripotent ES cells
and pre-implantation embryos
Initially, we examined the expression of BNP and its receptor,
NPR-A, in murine ES cells grown under self-renewal and
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5341differentiation conditions (Fig. 1). Polymerase chain reaction with
reverse transcription (RT-PCR) (Fig. 1A), Western blotting
(Fig. 1B), double-immunofluorescence (Fig. 1C, D), and flow
cytometry (Fig. 1E, F) analyses showed that BNP and NPR-A were
highly expressed in pluripotent ES (Oct-4-positive) cells that were
cultured in the presence of LIF, and that expression was down-
regulated upon differentiation induced by culturing ES cells
without LIF for 5 days (Fig. 1). The differentiated cells, which
were negative for oct-4 expression, were also negative for BNP and
NPR-A expressions (Fig. 1C, D). These results indicate that BNP
and NPR-A are specifically expressed in self-renewing ES cells.
To determine whether BNP, NPR-A and NPR-B are expressed in
pre-implantation embryos, 3.5-day-old murine blastocysts were
subjected to double-immunofluorescence analysis using anti-BNP,
anti-NPR-A, or anti-NPR-B antibodies, as well as an antibody against
Oct-4 (self-renewal marker). Consistent with their presence in the
undifferentiatedEScells,BNP,NPR-AandNPR-Bwereco-expressed
with the self-renewal regulator Oct-4 in the blastocyst (Fig. 2A–C).
Figure 1. BNP and NPR-A are expressed specifically in self-renewing ES cells. [A] RT-PCR analysis showing reductions in the levels of BNP
and NPR-A mRNA after culture with (+) LIF in the ES cell medium or without (2) LIF for 5 days in the differentiation medium. Oct-4 and nanog were
used as self-renewal markers, and b-actin was used as a loading control. [B] Western blot showing down-regulation of the BNP protein after LIF
removal in ES cells treated as in A. b-actin was used as a loading control. [C] Double-immunofluorescence images of ES cells treated as in A, stained
with antibodies against the ES cell marker Oct-4 and BNP, and counterstained with Hoechst reagent. [D] Immunofluorescence images of ES cells
treated as in A, stained with antibodies against Oct-4 and NPR-A, and counterstained with Hoechst reagent. Note that the BNP and NPRA signals are
down-regulated upon differentiation. [E] Flow cytometric analysis of cells treated as in A, showing the expression of BNP and Oct-4 in pluripotent ES
cells and differentiated ES cells. [F] Flow cytometric analysis of cells treated as in A, showing the expression of NPR-A and Oct-4 in pluripotent ES cells
and differentiated ES cells. Scale bars in C, D=20 mm.
doi:10.1371/journal.pone.0005341.g001
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embryo implantation and in undifferentiated ES cells.
BNP signaling regulates ES cell proliferation
BNP expression in undifferentiated ES cells and repression upon
differentiation suggested that it may play a role in maintaining
pluripotency. We investigated this possibility by examining the
effect of BNP knockdown in ES cells. A small interfering RNA
(siRNA)-based technique was employed to specifically knockdown
the BNP gene in undifferentiated ES cells that were maintained in
a feeder-free culture. Before siRNA transfection, the undifferen-
tiated status of the murine ES cells used for transfection was
confirmed by flow cytometry and immunofluorescence (for Oct-4-
positive cells). RT-PCR revealed a marked reduction in the level of
BNP mRNA at 48 h post-transfection in the ES cells that were
transfected with BNP-targeting siRNA (BNP siRNA), as compared
with the ES cells that were transfected with a non-targeting siRNA
(control siRNA) (Fig. 3A). This finding was confirmed by the
reductions in protein levels observed in Western blots (Fig. 3B, C).
Knockdown of BNP significantly reduced the number and colony
size of the ES cells, as compared with the ES cells that were treated
with the control siRNA (Fig. 3D, E).
To validate further the observed decrease in ES cell prolifer-
ation after BNP knockdown, siRNA-transfected cells were exposed
to bromo-deoxyuridine (BrdU), and its incorporation into ES cells
was quantified by immunofluorescence and flow cytometry. ES
cells were examined 48 h post-transfection and following pulsed
incorporation of BrdU (45 min). Flow cytometric analysis of BrdU,
which was performed concurrent with the analysis of the cellular
DNA content, showed a marked reduction in BrdU incorporation
in ES cells treated with BNP siRNA (Fig. 3F). Likewise, we
observed a significant reduction in the number of BrdU-positive
cells in the BNP siRNA-treated cells, as compared to the control
siRNA-treated cells, as shown by immunofluorescence (Fig. 3G,
H). These results suggest that knockdown of BNP signaling has a
significant effect in decreasing the rate of DNA synthesis.
To assess directly the effect of BNP knockdown on the cell cycle
profile, we analyzed the phases of the cell cycle 48 h after siRNA
transfection. There was a significant reduction in the proportion of
cells in S phase, and an increase in the proportion of cells in G1
and G2/M phases in ES cells treated with BNP siRNA (Fig. 4A,
B). In contrast, there were no significant changes in the cell cycle
profile of differentiated ES cells after BNP knockdown (Fig. 4C).
These results suggest that inhibition of endogenous BNP
suppresses DNA synthesis as a result of the reduction of the cells
in the S phase in undifferentiated ES cells.
Furthermore, we examined the effect of exogenous BNP on ES
cell proliferation. The presence of NPR-A in ES cells (Fig. 1A, D),
suggests that BNP signaling can be transduced in ES cells via NPR-
A. BNP addition to ES cells in low-density ES cell cultures, as
previously reported [15], resulted in increased ES cell prolifera-
tion, as evidenced by the ES cell morphology (Supplemental
Fig. 1A). However, the proliferative potency of exogenous BNP
appeared to be lower than that of endogenously produced BNP,
suggesting that the BNP/NPR-A signaling produced by ES cells
masks the effect of exogenous BNP on ES cell proliferation.
BNP knockdown and exogenous BNP have no effect on
the ES cell pluripotent markers
The reduction in ES cell proliferation caused by abrogation of
BNP signaling had no effect on the undifferentiated status of the
ES cells, as determined by morphologic examination (Fig. 3E) and
confirmed by measurements of alkaline phosphatase activity,
which revealed that the levels of self-renewal in the control siRNA-
and BNP siRNA–treated cells were identical (Fig. 5A). In addition,
examination of the pluripotent ES cell markers Oct-4 and nanog
Figure 2. BNP and its receptors are expressed in pre-implantation embryos. Double-immunofluorescence images of 3.5-day-old blastocysts
stained with antibodies against BNP and Oct-4 [A], NPR-A and Oct-4 [B], or NPR-B and Oct-4 [C], and counterstained with Hoechst reagent. Scale
bars=20 mm.
doi:10.1371/journal.pone.0005341.g002
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Thus, ES cells treated with BNP siRNA expressed nanog mRNA
(Fig. 3A, 5B) and Oct-4 mRNA and protein (Fig. 3A, 5C) at levels
equivalent to those in ES cells treated with the control siRNA.
Also, addition of BNP to ES cell cultures promotes ES cell
propagation (Fig. S1A) without loss of pluripotent markers, as
assessed by alkaline phosphatase activity 4 days after BNP
addition (Fig. S1B). These findings indicate that reducing BNP
does not affect ES cell pluripotent markers, and underline the role
of BNP in undifferentiated murine ES cells rather than in
spontaneously differentiated progeny.
BNP knockdown suppresses cGMP production and NPR-B
mRNA
In addition, we measured the intracellular levels of cGMP, to
determine whether the cGMP pathway is involved in the effects of
BNP knockdown on ES cells. The levels of cGMP were reduced
significantly in ES cells treated with BNP siRNA, as compared to
the levels in ES cells treated with the control siRNA (Fig. 6A). It is
known that the natriuretic peptides -induced cGMP production is
mainly due to the activation of NPR-A and/or NPR-B.
Examination of NPR-A and NPR-B genes showed that NPR-B
mRNA was markedly reduced in ES cells treated with BNP
Figure 3. Knockdown of BNP suppresses ES cell proliferation. [A] RT-PCR analysis of ES cells transfected with the control siRNA or BNP siRNA,
showing knockdown of the BNP gene 48 h after siRNA transfection. siRNA-mediated knockdown of BNP has no effect on the self-renewal marker
genes (Oct-4 and nanog). b-actin was used as the internal control. [B] Western blot analysis of ES cells treated as in A, showing a reduced level of BNP
protein 48 h after siRNA transfection. b-actin was used as a loading control. [C] Quantification of B (n=3). [D] Quantification of ES cells 72 h after
siRNA transfection (n=3). [E] Morphologies of murine ES cells 48 h and 72 h after transfection with the control siRNA or BNP siRNA. [F] Flow
cytometric analysis of BrdU incorporation in ES cells treated as in A. X-axis, DNA content, as shown by propidium iodide (PI) binding; y-axis, BrdU
uptake after 45 min of exposure. [G] Immunofluorescence of BrdU incorporation (45 min) 48 h after transfection with the control siRNA or BNP
siRNA. [H] Percentage of BrdU-positive nuclei in A (n=30 fields). Data represent mean6s.d (p-value from two-tailed Student’s t-test). Scale bars,
100 mm( E), 20 mm( G).
doi:10.1371/journal.pone.0005341.g003
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siRNA, and no change was observed in the levels of NPR-A
mRNA (Fig. 6B). These results suggest that the cGMP reduction
was mainly due to the suppression of NPR-B gene.
Knockdown of BNP signaling up-regulates GABAAR genes
To elucidate the mechanisms underlying the effects of BNP
signaling on ES cell proliferation, we used Real-Time PCR to
analyze the expression level of GABAAR 48 h after siRNA
transfection. We found that the expression levels of the GABAAR
a1 and b3 subunits, which are the major units of GABAARi nE S
cells, were significantly up-regulated (Fig. 7A) in response to the
suppression of BNP in ES cells.
To determine whether the elevated levels of the GABAAR
subunits in BNP-knockdown ES cells are associated with the
activation of c-H2AX, as previously described [16], we examined
the level of c-H2AX by Western blotting. As expected for the
presence of GABAAR up-regulation, c-H2AX was expressed more
abundantly in ES cells treated with BNP siRNA than in those
treated with control siRNA (Fig. 7B). Furthermore, immunoflu-
orescence analysis revealed the accumulation of c-H2AX nuclear
foci in response to BNP knockdown (Fig. 7C).
Furthermore, activation of endogenous GABAAR with musci-
mol (a GABAAR agonist) in low-density cultures, significantly
reduced the BNP mRNA (Fig. 7D) and protein (Fig. 7E) levels,
which are associated with reductions in ES cell proliferation,
suggesting a regulatory mechanism between endogenous BNP and
GABAAR signaling for the control of ES cell proliferation.
Knockdown of BNP signaling induces apoptosis and
down-regulates Ets-1
The reduced cell numbers and colony size that we observed in
ES cells after BNP knockdown could be caused by increased cell
death and/or decreased cell proliferation. Therefore, the apoptosis
assay was performed using Annexin V as a marker for apoptotic
cells. Flow cytometric analysis showed that the percentage of cells
undergoing apoptosis significantly increased in the BNP siRNA-
treated cells, as compared to the control siRNA-treated cells
(Fig. 7F). These data indicate that BNP plays an important role in
maintaining ES cell survival. However, it is known that GABAAR
activation does not cause apoptosis or DNA damage in ES cells.
Therefore, we examined the phosphoinositide 3-kinase (PI3K)
pathway, which is known to be involved in proliferation and
growth of ES cells by stimulating the G1-S phase transition, and its
inhibition induces apoptosis in ES cells [17]. Western blot (Fig.
S2A–B) and flow cytometry (Fig. S2C) analyses revealed no
change in the level of phospho-Akt (ser 473), a marker for PI3K,
suggesting that BNP signaling does not interfere with PI3K
pathway. Furthermore, we examined the mRNA levels of the
transcription factor Ets-1, which is required for normal survival of
Figure 4. Effect of BNP Knockdown on ES cell cycle in murine ES cells. [A] Cell cycle distribution of ES cells 48 h after transfection with
control siRNA or BNP siRNA. [B] Percentages of cells in G1, S, and G2/M phases of cell cycle (n=3). [C] Cell cycle analysis of differentiated ES cells
(6 days without LIF), 48 h after transfection with the control siRNA or BNP siRNA show no significant difference after BNP knockdown..
doi:10.1371/journal.pone.0005341.g004
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Ets-1 significantly down-regulated (Fig. 7G) at 48 h and 72 h from
transfection in ES cells treated with BNP siRNA, indicating that
BNP is required for the activation of Ets-1 in ES cells.
Discussion
In the present study we demonstrate for the first time that
undifferentiated murine ES cells express BNP and its receptor. We
also report that BNP signaling is essential for murine ES cell
survival and their clonal growth, through the suppression of
GABAAR genes and activation of the transcription factor Ets-1.
Together, these findings establish BNP as a novel regulator for
murine ES cell proliferation.
The results showed that the expression of BNP and NPR-A were
observed only in Oct-4-positive cells in the undifferentiated ES cells
and the pre-implantation embryos. These results establish defini-
tively that BNP and NPR-A are specifically expressed in self-
renewingEScells.Duringdevelopment,Oct-4expressionisrequired
to maintain the pluripotent cell population of the inner cell mass
(ICM) andepiblast.In addition,Oct-4ishighlyexpressed in EScells,
and without this factor, these cells differentiate along the trophoblast
lineage [18].These findings suggest that BNP may exert regulatory
functions prior to embryo implantation and in undifferentiated ES
cells. Therefore, we investigated this possibility by examining the
effect of BNP knockdown in ES cells, which significantly suppressed
ES cell proliferation by decreasing the percentage of cells in S phase
(DNA synthesis phase) and accumulation of cells in G1 and G2/M
phases. The mechanism underlying the accumulation of cells in G2/
M cell cycle phases is unknown, which suggest that BNP may has a
role in regulating G2/M cell cycle transition, as well as G1/S in ES
cells. These findings suggest the important role of endogenous BNP
in maintaining the ES cell proliferation.
BNP is known to play a role in cell growth [12,15]. A transgenic
mouse over-expressing BNP exhibited marked skeletal overgrowth,
and studies using in vitro organ culture of mouse tibia
demonstrated that BNP increases cGMP production and activates
the proliferation of growth plate chondrocytes via GC-coupled
natriuretic peptide receptors [12]. In contrast, no skeletal defects
are reported in transgenic mice overexpressing ANP [19],
although ANP and BNP have similar affinity to known GC-
coupled natriuretic peptide receptors [8,20]. It is interesting to
Figure 5. BNP knockdown does not affect on the ES cell pluripotency. [A] Alkaline phosphatase staining of ES cells 4 days after transfection
with control siRNA or BNP siRNA. [B] Real-time PCR analysis shows equal level of nanog mRNA (pluripotent marker) in ES cells 48 h after siRNA
transfection with control siRNA or BNP siRNA (n=3). [C] Flow cytometric analysis of Oct-4 expression (a marker of pluripotency) in ES cells treated as
in A, shows no significant difference in Oct-4 levels after BNP knockdown. Data represent mean6s.d (p-value from two-tailed Student’s t-test). Scale
bars, 10 mm( F).
doi:10.1371/journal.pone.0005341.g005
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phenotype than ANP-deficient mice [22]. Mice without BNP do
not have hypertension; instead they show focal ventricular fibrosis
[21]. This had led to the speculation that there may be a separate
unknown receptor for BNP in cardiac fibroblasts.
However, in cultures of embryonic mouse tibias, BNP and CNP
increased bone growth and stimulated cGMP production by
signaling through NPR-B [23]. Moreover, Mice lacking NPR-A
exhibit cardiac hypertrophy, hypertension, fibrosis [24]. These
findings agree with our results, which showed that BNP knockdown
inEScellsledtoamarkeddecreaseinintracellularcGMPlevelanda
significant reduction in mRNA level of NPR-B. It is possible that the
reduced cGMP level in ES cells is a reflection of the reduced NPR-B
mRNA level. This hypothesis represents the signaling pathway
through NPR-B as a possible regulator for ES cell proliferation.
However, further studies are needed to elucidate the role of NPR-B
in ES cell proliferation. It has been reported that mice lacking NPR-
B were sterile due to lack of development of the reproductive system
[14]. Furthermore, in the current study NPR-B expression was
detected in Oct-4-positive cells of the pre-implantation embryos,
suggesting a role of NPR-B in early stages of development. Taken
together, these findings suggest that BNP could be exerting its
proliferative effects through either NPR-A, its preferred receptor or
through NPR-B, for which it has reasonable affinity [25].
BNP knockdown led to up-regulation of GABAAR genes.
Furthermore, the GABAAR activation led to suppression of BNP
expression in ES cells. Recently, the a1 and b3 subunits have been
found to be the major subunits of GABAARs in ES cells, and they
negatively regulate ES cell proliferation through a phosphorylated
histone (c-H2AX)-dependent mechanism [17]. However, the
correlation between BNP and GABAAR has been previously
determined, whereby BNP suppresses GABAAR currents in retinal
bipolar cells [26]. These findings suggest that endogenous BNP
signaling is important for inhibiting the GABAAR levels in ES
cells, which in turn promotes ES cell proliferation.
Also, we found that BNP knockdown led to accumulation of c-
H2AX in ES cells. H2AX is considered to be critical for the
surveillance of genome integrity [27]. It was found that GABAAR
activation led to phosphorylation of H2AX in cell cycle-dependent
and DNA damage-independent manners [16,28]. However, our
results showed an increase in the rate of apoptosis in the BNP
siRNA-treated cells. Taken together, these findings suggest that
accumulation of c-H2AX after BNP knockdown in ES cells may
be as a result of the activation of GABAARs and/or apoptosis.
BNP knockdown in ES cells led to a marked reduction in the
transcription factor Ets-1. Ets-1 was shown to be required for the
normal survival of T cells, and Ets-1
2/2 T cells displayed a severe
proliferative defect and demonstrated increased rates of sponta-
neous apoptosis, indicating anti-apoptotic role [29,30]. In
addition, Ets-1 was reported to participate in the activation of
BNP gene [31]. Furthermore, NPR-A gene transcription and
guanylyl cyclase (GC) activity of the receptor are critically
regulated by Ets-1 in target cells [32]. Although, there is no data
available about the role of Ets-1 in ES cell proliferation, these
results indicate that the Ets-1 may be involved in the anti-
apoptotic and proliferative effects of endogenous BNP on ES cells.
In summary, our data establish BNP as an essential regulator for
the proliferation of murine ES cells. The undifferentiated ES cells
express high levels of BNP and its specific receptor. Knockdown of
BNP in ES cells led to a marked decrease in ES cell proliferation
through a cGMP-dependent mechanism. The reduction of ES cell
number observed in BNP siRNA-treated cells was primarily due to
GABAAR activation, c-H2AX accumulation, Ets-1 inhibition and
apoptosis induction (Fig. 8). The present study defines a new
pathway that is mediated by BNP-GABAAR for control ES cell
propagation in vitro (Fig. 8). These findings will facilitate our
understanding of the signaling pathways that maintain the unusual
proliferative characteristics of ES cells.
Materials and Methods
ES Cell Culture
Murine ES cells (E14TG2a) (CRL-1821; American Type
Culture Collection, Manassas, VA, USA) were maintained in
Figure 6. siRNA-mediated knockdown of BNP reduces cGMP production and NPR-B mRNA. [A] cGMP assay of ES cells 48 h after ES cell
transfection with the control siRNA or BNP siRNA. [B] PCR analysis of NPR-A and NPR-B 48 h after ES cell transfection with the control siRNA or BNP
siRNA . Data represent mean6s.d (n=3; p-value from two-tailed Student’s t-test).
doi:10.1371/journal.pone.0005341.g006
Role of BNP in ES Cells
PLoS ONE | www.plosone.org 7 April 2009 | Volume 4 | Issue 4 | e5341DMEM/F-12 medium (Sigma) that was supplemented with 1000
U/ml LIF (Chemicon), 11% FBS, 2 mM glutamine (Nacalai
Tesque, Japan), 1 mM sodium pyruvate (Sigma), 1% MEM
nonessential amino acids (GIBCO), 0.1 mM 2-mercaptoethanol
(Sigma) and 1% penicillin-streptomycin. For siRNA transfection,
ES cells were cultured in the same medium, except that FBS was
replaced with 15% Knockout Serum Replacement (KSR;
GIBCO). Murine ES cells were cultured under feeder-free
conditions in the presence of LIF. For differentiation, embryoid
bodies were grown in bacteriologic dishes without LIF and b-
mercaptoethanol for 5 days, as described previously [33]. Murine
BNP (American Peptide) and muscimol (Tocris) [16] were added
at 1 mM and 100 mM, respectively, to the cultured ES cells, while
the control cells received vehicle alone.
Immunofluorescence
ES cells grown on glass coverslips were rinsed briefly with PBS
and fixed for 20 min in 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4). Blastocysts were collected from ICR mice at 3.5
dpc and fixed in 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4). All experimental procedures and protocols were
reviewed and approved by the Institutional Animal Care and
Use Committee of the Shiga University of Medical Science, Otsu,
Japan and conformed to the NIH Guide for the Care and Use of
Laboratory Animals.
The ES cells and blastocysts were permeabilized for 10 min
with 0.1% Triton X-100 in PBS, and blocked for 40 min with 4%
BSA in PBS at room temperature (RT). They were then incubated
at 4uC overnight with the following antibodies; anti-BNP (1:1000;
Chemicon), anti-NPR-A (1:300; Abcam), anti-NPR-B (1:200,
Abcam), anti-Oct-4 (1:200, sc-5279; Santa Cruz Biotechnology),
and anti-c-H2AX IgG (1: 500; Upstate). This was followed by
incubation with the following secondary antibodies; Chromeo
546-labelled anti-mouse IgG (1:1000; Active Motif Chromeon
GmbH, Tegernheim, Germany), Alexa Fluor 488-labeled anti-
mouse IgG, and Alexa Fluor 488-labeled anti-rabbit IgG (1:500;
Molecular Probes). Nuclei were counterstained with Hoechst
33342 (1 mg/ml) (Invitrogen). The slides were examined by
confocal laser microscopy (C1si; Nikon, Japan) and the images
were processed using the Nikon EZ-C1 viewer software.
Immunofluorescence analysis of BrdU incorporation was
performed as described previously [34]. BrdU (1:100; Invitrogen)
was added to the culture medium 48 h after transfection, and the
incubation was continued for an additional 45 min. Cells were
Figure 7. BNP knockdown upregulates GABAAR genes, induces apoptosis and downregulates Ets-1 in murine ES cells. [A] Real-time
PCR analysis of the mRNA levels for the GABAAR a1 and GABAAR b3 subunits 48 h after ES cell transfection with the control siRNA or BNP siRNA. [B]E S
cells treated as in A were analyzed by Western blotting using the anti-c-H2AX antibody. b-actin is shown as a control for loading. [C]
Immunofluorescence analysis shows the distribution of c-H2AX foci (green) in ES cells treated as in A and B. DNA was counterstained with Hoechst
reagent (blue). [D] PCR analysis of ES cells for BNP expression after 24 h of exposure to muscimol. [E] Western blot analysis of BNP in ES cells treated
as in D.[ F] Apoptosis assay 48 h after transfection with control siRNA or BNP siRNA. Flow cytometry profile represents Annexin-V-FITC staining in x
axis and PI in y axis. The number represents the percentage of early apoptotic cells in each condition (lower right quadrant) (n=2; p-value=0.016).
[G] PCR analysis of Ets-1 mRNA 48h and 72 h after ES cell transfection with the control siRNA or BNP siRNA. Data represent mean6s.d (n=3; p-value
from two-tailed Student’s t-test).
doi:10.1371/journal.pone.0005341.g007
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antibody (1:200; Molecular Probes) in 2% BSA-PBS overnight at
4uC. The percentage of BrdU-positive nuclei relative to the total
number of nuclei per field of vision was determined. A minimum
of five fields of vision per coverslip was counted.
Reverse Transcription-Polymerase Chain Reaction (PCR)
and Real-Time PCR
Total RNA was extracted using the RNeasy Mini kit (Qiagen)
according to the manufacturer’s instructions. cDNA synthesis was
performed with 1 mg of total RNA using the Superscript III first-
stand cDNA synthesis kit (Invitrogen). The cDNA (0.5 mg) was
used as a template in a mixture that contained Ampli Taq Gold
polymerase (Applied Biosystems). RT-PCR was performed with an
annealing temperature of 58uC.
The cDNA samples were analyzed by Real-Time PCR in a
LightCycler Real-Time PCR system (Roche Diagnostics) using the
SYBR Premix Ex Taq II (Takara, Japan). Standard curves were
generated for each Real-Time PCR run using serial 5-fold dilutions
of samples that contained the gene of interest. Following PCR, the
specificities and identities of the RT-PCR products were verified
using melting curveanalysis;thisanalysisdistinguishedspecificPCR
products from non-specific PCR products that arose from primer-
dimer formation. The reactions were carried out in triplicates. The
relative mRNA levels were determined from the appropriate
standard curves and corrected for the b-actin mRNA levels.
The primer sequences (forward and reverse) were as follows:
BNP, 59-CTGAAGGTGCTGTCCCAGATG-39 and 59- GACG-
GATCCGATCCGGTC-39; NPR-A, 59-AGTACGCCAACAAC-
CTGGAG-39 , and AAGAGCTGTAAAGCCCACGA-39; Oct-4,
59-GGATGCTGTGAGCCAAGG-39, and 59-GAACAAAATG-
ATGAGTGACAGACAG-39 ; Nanog, 59-CACCCACCCATG-
CTAGTCTT-39 and 59-ACCCTCAAACTCCTGGTCCT-39 ;
Ets-1, 59-CATATCAGGTTAATGGAGCC-39 and 59-GTAG-
TCGAAGCTGTCATAGG-39 ; GABAAR a1, 59-TTTGGGA-
GAGCGTGTAACTGAA-39 and 59-ACTCCATATCGTGGT-
CTGAAACTG-39; GABAAR b3, 59-AATCAAAATCCCT-
GATCTAACCGA-39 and 59-AAGAGAGAAAAGGTGAATG-
GAAACA-39; NPR-B, 59-TCATGACAGCCCATGGGAAA-39
and 59-GGTGACAATGCAGATGTTGG-39; b-actin, 59-TGG-
TGGGCATGGGTCAGAAGGATTC-39 and 59-CATGGCTG-
GGGTGTTGAAGGTCTCA-39.
RNA Interference
RNA interference in murine ES cells was carried out according
to the manufacturer’s protocol using Lipofectamine 2000
(Invitrogen) in 6-well plates. Two pairs of siRNAs (Invitrogen)
were designed for BNP (NM_008726) using the BLOCK-iT RNAi
Designer software. BNP siRNA1 gave higher level of BNP
knockdown and therefore used for all subsequent experiments.
The appropriate siRNA negative control Duplex (Cat. No. 12935-
300; Invitrogen) was selected based on the percentage G/C. The
BNP siRNA and control siRNA were transfected at a final
concentration of 40 mM for 24 h in triplicate for each treatment.
At 48 h post-transfection, BNP knockdown was confirmed by RT-
PCR and Western blotting. The sequences of BNP siRNAs were
as follows:
BNP siRNA1: sense, 59-CCCAGAGACAGCUCUUGAATT-
39; antisense, 59- UUCAAGAGCUGUCUCUGGGTT-39.
BNP siRNA2: sense, 59-GGCACAAGAUAGACCGGAUTT-
39; antisense, 59- AUCCGGUCUAUCUUGUGCCTT-39.
Western Blotting
Total protein extracts were prepared from ES cells, dissolved in
SDS-PAGE buffer, and transferred to nitrocellulose membranes
(Amersham Biosciences, Germany). Proteins were detected using
antibodies against BNP (1:2000; Chemicon), c-H2AX (1: 1000;
Upstate), phospho-Akt (Ser 473) (1: 1000, Cell Signaling), and b-
actin (1:6000, sc-47778; Santa Cruz Biotechnology). The second-
ary antibodies were: Histofine anti-rabbit IgG complex or
Histofine anti-mouse IgG complex (1:50; Nichirei, Japan). The
blots were developed using the SuperSignal West Pico Chemilu-
Figure 8. Proposed model of BNP-mediated maintenance of ES cell proliferation. BNP suppresses GABAAR, which in turn suppresses the
phosphorylation of H2AX into c-H2AX. As a result, activation of ES cell proliferation occurs. Also, the activation of GABAAR leads to suppression of
BNP. In other pathways, BNP activates NPR-B and Ets-1, which may enhance the proliferation and survival of ES cells.
doi:10.1371/journal.pone.0005341.g008
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FujiFilm Lumino-Image Analyzer (FujiFilm, Tokyo, Japan).
Flow Cytometry
Cells were fixed in 4% paraformaldehyde for 15 min at RT, and
washed with PBS that contained 2% FBS. Cells were incubated for
3 min in 100% ethanol, and blocked in 2% BSA for 20 min at RT.
For staining for Oct-4 or double-labeling for BNP and Oct-4 or
NPR-A and Oct-4, the cells were incubated for 1 h on ice with the
following primary antibodies: anti-BNP (1:1000; Chemicon); anti-
NPR-A (1:200; Abcam); and anti-Oct-4 (1:200; Santa Cruz
Biotechnology). This was followed by incubation for 1 h at RT
withAlexa Fluor488-conjugated anti-rabbitantibodyand/orAlexa
Fluor 647-conjugated anti-mouse antibody (1:200; Molecular
Probes). Data acquisition was performed using a FACSCalibur
(BD Biosciences) and the data were analyzed using the CellQuest
program. At least 10,000 events were collected for each sample.
Cell cycle analysis. The cells were fixed overnight in 70%
ethanol at 4uC. Enzymatic removal of RNA was carried out using
100 mg/ml RNase (Boehringer Mannheim GmbH, Mannheim,
Germany) at RT for 20 min. The cells were then stained with
5 mg/ml propidium iodide (PI; Sigma) at 4uC for 40 min. Flow
cytometric analysis was carried out on 20,000 gated events. The
cell cycle phase distribution was analyzed using the MODFIT-LT
Flow Cytometry Modeling Software (Verity Software House).
Bromodeoxyuridine (BrdU) incorporation. The level of
BrdU incorporation was measured together with the DNA content.
ES cells 48 h after siRNA transfection were pulsed (45 min) with
BrdU (1:100; Invitrogen). ES cells were dispersed into single cells;
the cells were fixed overnight in 70% ethanol at 4uC. DNA
denaturationwassubsequentlyperformedbyincubationin1 NHCl
for 20 min at room temperature. The cells then washed and
incubated with 0.1 M sodium tetraborate for 10 min at room
temperature. The cells were incubated with Alexa Fluor 488-
conjugated mouse anti-BrdU antibody (1:100; Molecular Probes) in
2% BSA-PBS for 2 h at 4uC. The cells were then incubated with
100 mg/ml RNase (Boehringer Mannheim) for 15 min, followed by
40 min of incubation in freshly prepared PI (5 mg/ml).At least
10,000 cells events were recorded for each sample using a
FACSCalibur (BD Biosciences) and analyzed using the CellQuest
program. The samples were subjected to two-parameter dot plot
histogram analysis (BrdU incorporation vs. DNA content).
Alkaline Phosphatase (ALP) Activity Assay
Staining for alkaline phosphatase (ALP) was performed at room
temperature using an alkaline phosphatase kit (Chemicon),
according to the manufacturer’s instructions. During reaction,
culture dishes were protected from drying and direct light. Images
were observed under an inverted microscope (Nikon, Japan).
Cell Proliferation Assay
In order to determine the number of cells, the cells were washed
with PBS and trypsinized from the culture dishes. The cell
suspension was mixed with trypan blue solution, and the number
of live cells was determined using a homocytometer. Cells failing to
exclude the dye were considered nonviable.
Apoptosis Assay
Annexin V/propidium iodide (PI) staining was performed using
flow cyometry according to the manufacturer’s guidelines (MBL,
USA). Briefly, ES cells were washed in ice-cold PBS. The cells
were then resuspended in 500 ml of binding buffer and incubated
with 5 ml of Annexin V-EGFP and 5 ml of PI for 10 min in the
dark at room temperature. Flow cytometric analysis was
immediately performed using a FACSCalibur (BD Biosciences).
Intracellular cGMP Assay
Cells were lyzed with 0.1 M HCl containing 0.1% Triton X-
100 at RT for 20 min. The lysates were centrifuged, and the levels
of cGMP in the supernatants were measured with a cGMP
enzyme immunoassay kit (Assay Designs).
Statistical Analysis
The results are expressed as mean s.d., as indicated in the figure
legends. Statistical significance was determined using the paired
Student’s t-test.
Supporting Information
Figure S1 Exogenous BNP enhances ES cell proliferation
without affecting ES cell pluripotency. [A] ES cell colonies 3 days
after exposure to BNP. ES cells were supplemented with 1 mM
BNP daily for 3 days in low-density cell cultures. [B] The alkaline
phosphatase activities of the ES cells were measured after 4 days in
the presence or absence of 1 mM BNP. Scale bars: A, 100 mm; B,
10 mm.
Found at: doi:10.1371/journal.pone.0005341.s001 (0.08 MB
PDF)
Figure S2 Effect of BNP signaling on phosphoinositide 3-kinase
(PI3K). [A] Western blot analysis for phosphor-Akt (Ser 473) 48 h
after siRNA transfection. [B] Western blot analysis for phosphor-
Akt (Ser 473) after 24 h exposure to BNP (1 mM). [C] Flow
cytometric analysis of phosphor-Akt (Ser 473) 48 h after siRNA
transfection.
Found at: doi:10.1371/journal.pone.0005341.s002 (0.16 MB
PDF)
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